ALEXANDRA WILLIAMS: Open Payments
NPI 1730782731 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 21 payments from 12 companies in 2025. Trend: 2023 $525 · 2024 $455 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Novo Nordisk Inc | 2 | $42 |
| PFIZER INC. | 2 | $39 |
| Amgen Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Abbott Laboratories | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
Products named: AIRSUPRA, NURTEC ODT, VRAYLAR, OTEZLA, CAPLYTA, TRELEGY ELLIPTA, Wegovy, FREESTYLE LIBRE 3.
Industry payments across VA — which companies pay providers there.
